The U.S. Food and Drug Administration (FDA) released a statement on May 31, 2022, that its Center for Devices and Radiological Health (CDRH) will once again be accepting all pre-submissions for all in vitro diagnostic (IVD) tests, not just COVID-19 tests. During the height of the pandemic and while inundated with COVID-related submissions, CDRH restricted the IVD tests it would review in order to best address the public health crisis. Starting June 1, 2022, CDRH is again accepting all IVD pre-submissions, both COVID-related and other. However, the Center did include the caveat that non-COVID pre-submissions will likely still face an extended timeline, given the ongoing pandemic and associated workload.
Read the full blog post.